Our business is breakthroughs

We take cutting-edge innovations from the lab bench to the bedside, translating them into effective tools, treatments and diagnostics for people with cancer.

 

Find out more
A scientist wearing goggles and a white lab coat looking at a cell image.

14

marketed drugs

1.5m+

life years* gained by cancer patients through drugs we helped to market

£600m+

revenue from royalties and IP

150+

active licences

95+

start-ups

Innovate and work with us

A scientist wearing google and a lab coat examining a sample.

Researchers

We support innovative research that can benefit society. Let us help you turn your ideas into meaningful progress for patients.

Woman speaking to man

Partners

We de-risk innovation by turning promising science into high-value assets. Partner with us for access to our extensive network and portfolio.

Man and woman looking at PC screen

Investors

We invest and co-invest in societal progress, and in the people who can turn ideas into a business reality. Explore investment opportunities with us.

UCB logo with tagline: Inspired by patients. Driven by science.

UCB, Cancer Research UK and Cancer Research Horizons announce new strategic alliance to accelerate development of novel cancer therapies

Latest news

The collaboration will unite Cancer Research UK’s and Cancer Research Horizons’ world‑leading oncology expertise with UCB’s strengths in discovery and development to advance a pipeline of novel investigational oncology candidates.

Learn more
Phil Masterson speaking at the Investor Networking Breakfast in November 2024

The rise of alternative investors in oncology innovation

Featured story

The UK has world‑class oncology research, but gaps in early‑stage funding are holding back the scalable spin‑outs needed to turn that research into patient benefit. A growing cohort of alternative investors is beginning to close those gaps. 

Learn more
A man wearing glasses and a blue blazer sits at a booth, deep in conversation with someone off-frame. He wears a lanyard with the Cancer Research Horizons logo on it.

The cutting-edge of translational oncology - directly to your inbox

Sign up to our newsletter

Receive quarterly updates featuring expert insights on emerging trends and thought leadership from those shaping the future of oncology innovation, specifically hand-picked by our team.  

You’ll also get the latest on our work in drug discovery, clinical trials, licensing, partnerships, and investment – all in a clear, digestible format. 

Subscribe here

Latest news

A scientist in the lab looking at samples.

Drug discovery and development capabilities

Spotlight

We're committed to driving therapeutic innovation in oncology, with six drug discovery sites and one focus: accelerating the discovery and development of new therapeutics. Our expertise spans target identification, validation and clinical positioning, through Hit identification and lead optimisation to the selection of candidate drugs for regulatory development, for both small molecule and antibody modalities.

Through partnership with the Cancer Research UK Centre for Drug Development we can also offer access to the capabilities and infrastructure needed to demonstrate clinical potential.

Explore our capabilities

Our portfolio

Scientist in lab holding pipette

Explore our pipeline

We've played a role in delivering 14 new cancer treatments for patients. Explore our clinical and preclinical assets currently in development.

Female scientist in white lab coat in a lab

Licensing opportunities

Discover the innovations we have available for collaboration, that will help create the medicines of tomorrow.

Two women speaking to each other, one with back faced to camera and the other facing camera

Our start-up portfolio

With a growing portfolio of start-ups, we're bringing together the community to spark the next breakthrough in cancer research.

*Expressed as quality-adjusted life years (QUALYs).